167 related articles for article (PubMed ID: 27658647)
1. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
3. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract][Full Text] [Related]
4. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
5. A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid.
Kim GY; Park CY; Cho CH; Park JS; Jung ED; Jeon EJ
Endocrinol Metab (Seoul); 2015 Jun; 30(2):221-5. PubMed ID: 25491784
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT.
Tripathy S; Aggrawal S; Subudhi K; Kumar R; Narwal A
Clin Nucl Med; 2019 Sep; 44(9):e546-e547. PubMed ID: 31283604
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
10. A study of FoxA1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract][Full Text] [Related]
11. [Calcitonin: indications and interpretation].
d'Herbomez M
Presse Med; 2011 Dec; 40(12 Pt 1):1141-6. PubMed ID: 22035862
[TBL] [Abstract][Full Text] [Related]
12. Radiation-associated small cell neuroendocrine carcinoma of the thyroid: a case report with molecular analyses.
Mussazhanova Z; Miura S; Stanojevic B; Rougounovitch T; Saenko V; Shiraishi T; Kurashige T; Shichijo K; Kaneko K; Takahashi H; Ito M; Nakashima M
Thyroid; 2014 Mar; 24(3):593-8. PubMed ID: 23844610
[TBL] [Abstract][Full Text] [Related]
13. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.
Chen H; Sippel RS; O'Dorisio MS; Vinik AI; Lloyd RV; Pacak K;
Pancreas; 2010 Aug; 39(6):775-83. PubMed ID: 20664475
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.
Montgomery G; Collins L; Coghlin C; Ullah R
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32816938
[TBL] [Abstract][Full Text] [Related]
15. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature.
Gurkan E; Gurbuz Y; Tarkun I; Canturk Z; Cetinarslan B
Indian J Pathol Microbiol; 2014; 57(4):598-602. PubMed ID: 25308015
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract][Full Text] [Related]
17. Clinical challenges with calcitonin-negative medullary thyroid carcinoma.
Samà MT; Rossetto Giaccherino R; Gallo M; Felicetti F; Maletta F; Bonelli N; Piovesan A; Palestini N; Ghigo E; Arvat E
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2023-9. PubMed ID: 27125958
[TBL] [Abstract][Full Text] [Related]
18. Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance.
Rafaey W; Munir Alvi A; Siddiqi AI; Shafiq W; Irfan H
Cureus; 2022 Nov; 14(11):e32088. PubMed ID: 36600874
[TBL] [Abstract][Full Text] [Related]
19. Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.
Sukpanich R; Khanafshar E; Suh I; Gosnell J
AME Case Rep; 2019; 3():12. PubMed ID: 31231713
[TBL] [Abstract][Full Text] [Related]
20. Compact buds with biphasic differentiation and calcitonin-expressing neuroendocrine cells-previously unrecognized structures of thyroglossal duct unveiled by immunohistochemistry.
Keelawat S; Bychkov A
Virchows Arch; 2019 May; 474(5):609-617. PubMed ID: 30729310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]